Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Working Capital Changes (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Other Working Capital Changes for 13 consecutive years, with -$625000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes changed N/A to -$625000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$949000.0 through Dec 2025, down 29.64% year-over-year, with the annual reading at -$949000.0 for FY2025, 29.64% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$625000.0 at Niagen Bioscience, down from -$36000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $2.4 million in Q3 2022, with the low at -$2.7 million in Q4 2022.
  • Average Other Working Capital Changes over 5 years is -$115842.1, with a median of -$37000.0 recorded in 2025.
  • Peak annual rise in Other Working Capital Changes hit 3398.53% in 2022, while the deepest fall reached 34150.0% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $8000.0 in 2021, then tumbled by 34150.0% to -$2.7 million in 2022, then surged by 118.06% to $492000.0 in 2023, then crashed by 248.78% to -$732000.0 in 2024, then increased by 14.62% to -$625000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$625000.0, -$36000.0, and -$37000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.